I don't worry that the results from any of our trials will be bad, but I do worry about the possibility that the FDA, instead of approving us, kicks the Leronlimab can down the road after the results of our first trial are out. I can see them asking for a second trial to confirm the results, possibly in a larger patient population. That satisfies all their big pharma buddies who get an additional number of months to pad their already generous leads. But if we get the fast and exceptional results we'd expect from the Mexican collaboration we could end up with four very strong arguments for approval with the FDA in short order. We'd have strong results from three different studies, including a possible approval in Mexico. It would be very hard for the FDA to suppress Leronlimab at that point. That's why I like the trial in Mexico even more than I like the head to head with Remdesivir.

(I also don't have any evidence for this but I kinda feel like the Remdesivir trial isn't going to happen, not that NP would worry about Leronlimab crushing Remdesivir. I just think that it was 90% meant to force hands behind the scenes on some things and only 10% that they actually intend on running it. Weird gut feeling based on nothing.)

That being said, I'm still holding out hope that the FDA isn't a completely corrupt and heartless organization. They've been far less generous with leronlimab than they could have been but maybe they're in CYA mode and are just waiting for that first "official" evidence of the power of Leronlimab before shoving their chips into the pot.